ASIPP Responsible Opioid Prescribing In Chronic Non-Cancer Pain: Part 2 - Guidance Guideline Summary - Guideline Central
Recommendations
Document Overview

Responsible Opioid Prescribing In Chronic Non-Cancer Pain: Part 2 - Guidance

American Society of Interventional Pain Physicians


Publication Date: Jul 1, 2012

Page Last Updated: May 5, 2026


American Society of Interventional Pain Physicians Grading System


Document Overview

Document Title
Responsible Opioid Prescribing In Chronic Non-Cancer Pain: Part 2 - Guidance
Authoring Society

American Society of Interventional Pain Physicians

Document Publication Date
Jul 1, 2012
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.painphysicianjournal.com/2012/july/2012; 15;S67-S116.pdf
Source Citation
Pain Physician 2012; 15:S67-S116

Document Scope, Criteria, and Use Cases

Document Objectives
Guidelines on responsible opioid prescribing provides the recommendations for initiating and maintaining chronic opioid therapy of 90 days or longer.
Scope
Assessment and Screening, Counseling, Diagnosis, Management, Treatment
Diseases/Conditions (MeSH)

D059350 - Chronic Pain

D059408 - Pain Management

D000701 - Analgesics, Opioid

D009293 - Opioid-Related Disorders

D059350 - Chronic Pain

D059408 - Pain Management

D000701 - Analgesics, Opioid

D009293 - Opioid-Related Disorders

Keywords
Opioid Use Disorder, chronic pain, opioids
Target Patient Population
patient with chronic pain
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older Adult
Health Care Settings
Ambulatory, Hospice, Hospital, Long Term Care, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Data Supplement
Number of Source Documents
715
Includes peer/external review process?
Yes
Includes public comment process?
Yes
Methodologist involvement?
Yes
Patient involvement?
Yes
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
Yes
Identifies study selection process?
Yes
Identifies study selection criteria?
Yes
Identifies methods used to evaluate and analyze the evidence?
Yes
Identifies key questions addressed by the systematic review?
Yes
Identifies search strategy?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.